Precision Medicine Group

Precision Medicine Group is a global research, development, manufacturing and commercialization partner to life science innovators.

Precision for Value’s Jeremy Schafer is quoted in an article that discusses the naming of biosimilars. He concludes that the payer community will find a way to track biosimilar sourcing, usage and reimbursement regardless of naming conventions or HCPCS codes.

Precision for Medicine’s Karen M. Becker, PhD, comments on the Food and Drug Administration’s upcoming guidance on lab-developed tests for diagnosing conditions.

Dan Renick discusses precision medicine’s value in a *May* cover story, arguing that evidence must support therapeutic breakthroughs given limited resources.

Analysis from Medicare claims data from Precision’s Research Economist Joanna MacEwan, PhD at the American Diabetes Association 2015 Scientific Sessions.

Karen Becker, PhD, joins Precision for Medicine to help life science companies develop and commercialize next-generation medical products.

Precision for Medicine announces the appointment of four key executives to support medical diagnostic and device product development, including companion diagnostics.

Precision’s ethics and compliance code reflects its mission to improve drug development processes and accelerate life-changing treatments.

Founded in 2012, Precision Medicine Group transforms the process of bringing new drugs to market- integrating science, technology, data, and expertise.

Precision integrates sustainability into its strategy to accelerate drug development, expand patient access, and deliver impact for patients, employees, and communities.

Precision Medicine Group applies precision medicine expertise to advance science and improve health outcomes.

Precision Medicine Group provides a privacy notice for California residents working with or seeking work at the company.

Precision relies on data collection and processing to research, advise, and perform services for clients in drug development.

Precision Medicine Group advises clients in life sciences and biotechnology on clinical trials, drug discovery, and commercialization.

Precision upholds integrity in all business dealings, following anti-bribery laws in every country where it operates.

Precision Medicine Group commits to human rights, anti-slavery, and anti-human trafficking, adhering to laws and ethical standards in its operations.

Precision emphasizes fairness, integrity, and legal compliance across all business activities, encouraging employees and partners to uphold these standards.

Precision Medicine Group collaborates with third parties, prioritizing ethical behavior, client service, and mutual respect in business relationships.